Jean-Marc Bellemin
Director of Finance/CFO at IOVANCE BIOTHERAPEUTICS, INC.
Net worth: 868 096 $ as of 30/03/2024
Profile
Jean-Marc Bellemin holds the position of CFO & Principal Accounting Officer of Iovance Biotherapeutics, Inc. In the past he was Chief Financial Officer & Executive Vice President for Gritstone Oncology, Inc. and Senior Vice President-Business Solutions at Actelion Pharmaceuticals US, Inc. Mr. Bellemin received an undergraduate degree from Université Paris Dauphine-PSL, a graduate degree from Université Paris II Panthéon Assas and an MBA from ESSEC Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
29/02/2024 | 58,576 ( 0.02% ) | 868 096 $ | 30/03/2024 |
Jean-Marc Bellemin active positions
Companies | Position | Start |
---|---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 13/12/2020 |
Former positions of Jean-Marc Bellemin
Companies | Position | End |
---|---|---|
GRITSTONE BIO, INC. | Director of Finance/CFO | 10/12/2020 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 30/11/2017 |
Training of Jean-Marc Bellemin
Université Paris Dauphine-PSL | Undergraduate Degree |
ESSEC Business School | Masters Business Admin |
Université Paris II Panthéon Assas | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
GRITSTONE BIO, INC. | Health Technology |
Private companies | 1 |
---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Stock Market
- Insiders
- Jean-Marc Bellemin